JOHNSON MATTHEY PHARMACEUTICAL MATERIALS INC

Region I Settles EPCRA Case Against Johnson Matthey Pharmeutical Materials, Inc. of North Andover, Mass. On August 29, 2012, Region 1 filed a Consent Agreement and Final Order (“CAFO”) that simultaneously initiated and resolved an alleged violation of Section 313 of the Emergency Planning and Community Right-to-Know Act (“EPCRA”) by Johnson Matthey Pharmaceuticals Services of North Andover, Massachusetts. The CAFO alleged that the facility failed to submit the required Toxic Release Inventory Form for the chemical acetonitrile in 2009 and 2010 (forms for other toxic chemicals used at the facility were correctly submitted). This action is part of OECA’s EPCRA 313 non-filer initiative. Pursuant to the CAFO, Johnson Matthey Pharmaceutical Materials, Inc. will pay a civil penalty of $8,190.